Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -106,793 | -119,204 | -105,538 | -32,128 | -55,744 |
| Depreciation Amortization | -2,259 | 5,326 | 7,625 | 4,787 | 3,320 |
| Accounts receivable | -28,956 | 5,341 | -6,895 | 739 | -3,809 |
| Accounts payable and accrued liabilities | 4,812 | -1,225 | 2,708 | -1,141 | 2,253 |
| Other Working Capital | -34,375 | 104,405 | -17,620 | -11,486 | -23,264 |
| Other Operating Activity | 55,955 | 8,906 | 38,041 | -28,573 | 12,221 |
| Operating Cash Flow | $-111,616 | $3,549 | $-81,679 | $-67,802 | $-65,023 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,315 | -7,858 | -15,323 | -7,129 | -3,481 |
| Purchase Of Investment | -460,301 | -216,671 | -248,727 | -130,741 | -196,226 |
| Sale Of Investment | 460,692 | 189,498 | 166,726 | 138,385 | 148,576 |
| Other Investing Activity | 0 | 9 | 9 | 89 | 0 |
| Investing Cash Flow | $-3,924 | $-35,022 | $-97,315 | $604 | $-51,131 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 25,000 | 0 |
| Debt Repayment | -12,500 | -9,375 | N/A | -10,000 | -5,000 |
| Common Stock Issued | 12,285 | 56,538 | 2,485 | 1,861 | 180 |
| Common Stock Repurchased | N/A | N/A | -7 | N/A | N/A |
| Other Financing Activity | 137,769 | 1,150 | 778 | 252,386 | 636 |
| Financing Cash Flow | $137,554 | $48,313 | $3,256 | $269,247 | $-4,184 |
| Beginning Cash Position | 48,126 | 31,286 | 207,024 | 4,975 | 125,313 |
| End Cash Position | 70,140 | 48,126 | 31,286 | 207,024 | 4,975 |
| Net Cash Flow | $22,014 | $16,840 | $-175,738 | $202,049 | $-120,338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,616 | 3,549 | -81,679 | -67,802 | -65,023 |
| Capital Expenditure | -4,315 | -7,858 | -15,323 | -7,129 | -3,481 |
| Free Cash Flow | -115,931 | -4,309 | -97,002 | -74,931 | -68,504 |